Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

Related Articles by Review for PubMed (Select 23679310)

2.

A systematic overview of chemotherapy effects in breast cancer.

Bergh J, Jönsson PE, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):253-81. Review.

PMID:
11441936
3.

Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group.

Martin M, Villar A, Sole-Calvo A, Gonzalez R, Massuti B, Lizon J, Camps C, Carrato A, Casado A, Candel MT, Albanell J, Aranda J, Munarriz B, Campbell J, Diaz-Rubio E; GEICAM Group (Spanish Breast Cancer Research Group), Spain.

Ann Oncol. 2003 Jun;14(6):833-42. Review.

4.
5.

Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis.

Yu KD, Huang S, Zhang JX, Liu GY, Shao ZM.

BMC Cancer. 2013 May 16;13:240. doi: 10.1186/1471-2407-13-240. Review.

6.

WITHDRAWN: Multi-agent chemotherapy for early breast cancer.

Clarke MJ.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD000487. doi: 10.1002/14651858.CD000487.pub2. Review.

PMID:
18843612
7.

Multi-agent chemotherapy for early breast cancer.

Early Breast Cancer Trialists' Collaborative Group.

Cochrane Database Syst Rev. 2002;(1):CD000487. Review. Update in: Cochrane Database Syst Rev. 2008;(4):CD000487.

PMID:
11869577
8.

[Evolution of adjuvant chemotherapy of breast cancer from Bonadonna to the taxanes].

Nagykálnai T.

Magy Onkol. 2002;46(4):307-13. Epub 2003 Feb 1. Review. Hungarian.

9.

Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer.

Mauri D, Polyzos NP, Salanti G, Pavlidis N, Ioannidis JP.

J Natl Cancer Inst. 2008 Dec 17;100(24):1780-91. doi: 10.1093/jnci/djn414. Epub 2008 Dec 9. Review.

10.

Adjuvant anthracycline-based chemotherapy for early breast cancer: do the dose and schedule matter?

Mano MS, Awada A, Kerr J, Canney P.

Cancer Treat Rev. 2005 Apr;31(2):69-78. Epub 2005 Jan 22. Review.

PMID:
15847977
11.

[Adjuvant chemotherapy for breast cancer--a current controversy].

Jinno H, Ikeda T, Kubouchi K, Fujiwara K, Kitajima M.

Gan To Kagaku Ryoho. 2004 Feb;31(2):176-80. Review. Japanese.

PMID:
14997747
12.

Adjuvant treatments for triple-negative breast cancers.

Joensuu H, Gligorov J.

Ann Oncol. 2012 Aug;23 Suppl 6:vi40-5. Review.

13.

CMF revisited in the 21st century.

Munzone E, Curigliano G, Burstein HJ, Winer EP, Goldhirsch A.

Ann Oncol. 2012 Feb;23(2):305-11. doi: 10.1093/annonc/mdr309. Epub 2011 Jun 29. Review.

15.

Optimum anthracycline-based chemotherapy for early breast cancer.

Adlard JW, Dodwell DJ.

Lancet Oncol. 2001 Aug;2(8):469-74. Review.

PMID:
11905722
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk